FDA product code DWA: Control, Pump Speed, Cardiopulmonary Bypass
DWA is the FDA product code for control, pump speed, cardiopulmonary bypass. It is a Class II device, regulated under 21 CFR 870.4380 and reviewed by the Cardiovascular panel. FDA has cleared 37 510(k) submissions under DWA, 3 in the last five years, from 19 different applicants. The average 510(k) review took 115 days (median 83); 256 days on average over the last three years. FDA has posted 12 recalls for DWA devices, 3 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Control, Pump Speed, Cardiopulmonary Bypass |
| Device class | Class II |
| Regulation | 21 CFR 870.4380 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Life-sustaining or supporting | Yes |
510(k) clearances per year for DWA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 28 |
| 2020 | 2 | 111 |
| 2023 | 2 | 146 |
| 2024 | 1 | 256 |
Compare with all 510(k) review times · Search every DWA clearance
Top DWA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Levitronix, LLC | 6 | 2010-08-27 |
| Medtronic Bio-Medicus, Inc. | 6 | 1994-12-23 |
| Sorin Group Deutschland GmbH | 3 | 2011-09-20 |
| Stockert Instrumente GmbH | 3 | 2004-09-23 |
| Bio Medicus, Inc. | 3 | 1990-06-28 |
14 more applicants have DWA clearances. See the full list in Caduvo.
Most recent DWA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K232788 | Inspira Technologies Oxy B.H.N. , Ltd. | INSPIRA ART100 | 2024-05-24 | 256 |
| K230698 | Apmtd, Inc. | Anivia SG1000 Pump Console | 2023-04-18 | 36 |
| K221491 | Apmtd, Inc. | Anivia SG1000 Pump Console | 2023-02-03 | 256 |
| K192838 | Spectrum Medical , Ltd. | Quantumn Centrifugal Drive- High Pressure, Quantum Centrifugal Drive- Medium Pressure | 2020-04-13 | 193 |
| K200306 | Abbott (Formerly Thoratec Corporation) | CentriMag Circulatory Support System, CentriMag Return (Arterial) Cannula Kit, CentriMag Drainage (Venous) Cannula Kit | 2020-03-06 | 29 |
Recalls for DWA devices
12 product recalls in 10 recall events; 3 initiated in the last five years and 1 still open. Most recent: 2022-12-05.
| Year | Recalls |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 2 |
Frequently asked questions
What is FDA product code DWA?
DWA is the FDA product code for control, pump speed, cardiopulmonary bypass. It is a Class II device, regulated under 21 CFR 870.4380 and reviewed by the Cardiovascular panel.
What device class is DWA?
Class II, regulation 21 CFR 870.4380. Typical premarket route: 510(k).
How long does a 510(k) take for product code DWA?
Across 37 cleared submissions the average was 115 days from receipt to decision (median 83).
Which companies have the most DWA clearances?
Levitronix, LLC (6); Medtronic Bio-Medicus, Inc. (6); Sorin Group Deutschland GmbH (3); Stockert Instrumente GmbH (3); Bio Medicus, Inc. (3).
Have DWA devices been recalled?
Yes: 12 product recalls across 10 recall events; the most recent began 2022-12-05.
Next steps
- Run an FDA pathway report with predicate devices for product code DWA
- Run a recall and safety report across every DWA manufacturer
- Watch product code DWA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times